• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Durable complete response to early immunotherapy discontinuation in a kidney transplant recipient with advanced cutaneous squamous cell carcinoma: A case report and review of literature
CONCLUSION: Organ transplant recipients with complete response to immunotherapy for cutaneous squamous cell carcinoma may continue to respond despite early treatment cessation. This may reduce the risks of late immune-related adverse events and acute graft rejection.PMID:37734447 | DOI:10.1016/j.trim.2023.101932
Source: Transplant Immunology - September 21, 2023 Category: Transplant Surgery Authors: Ziyao Lu Mohammed Afzal Keisuke Shirai Source Type: research

Successful Shrinkage of a Giant Cutaneous Squamous Cell Carcinoma with Immunotherapy in a Kidney Transplant Recipient
Exp Clin Transplant. 2023 Jun;21(6):534-536. doi: 10.6002/ect.2023.0018.ABSTRACTA 56-year-old male living donor kidney transplant recipient presented with a giant cutaneous squamous cell carcinoma in his right parotid region. Programmed radiotherapy had been previously terminated due to lesion ulceration and bleeding. He was characterized as a terminal case. We applied cemiplimab, which is an immune checkpoint inhibitor against the pro-grammed cell death receptor PD-1. After 6 months, the cutaneous squamous cell carcinoma had shrunk and had stopped bleeding. The patient was treated with methylprednisolone, cyclosporine, an...
Source: Experimental and Clinical Transplantation : official journal of the Middle East Society for Organ Transplantation - July 17, 2023 Category: Transplant Surgery Authors: Theodoros Eleftheriadis Ioannis Samaras Antonios Spanos Athanasios Kotsakis Ioannis Stefanidis Source Type: research

Systematic Review of Calcineurin Inhibitors and Incidence of Skin Malignancies after Kidney Transplantation in Adult Patients: A Study of 309,551 Cases
In conclusion, the calcineurin inhibitors used after kidney transplantation are associated with a higher risk of skin cancer-both non-melanoma and melanoma-when compared with other immunosuppressive therapies. This finding suggests that careful monitoring for skin lesions in post-transplant patients must be conducted. However, the decision on the kind of immunotherapy used should always be considered on an individual basis for each renal transplant recipient.PMID:37366913 | DOI:10.3390/curroncol30060430
Source: Cancer Control - June 27, 2023 Category: Cancer & Oncology Authors: Aleksandra Kulbat Karolina Richter Tomasz Stefura Marta Ko łodziej-Rzepa Micha ł Kisielewski Tomasz Wojewoda Wojciech M Wysocki Source Type: research

Squamous Cell Carcinoma of the Kidney: A Large Case Series
CONCLUSIONS: SCC of the kidney is a rare upper urinary tract neoplasm reported in the literature. The gradual onset of vague symptoms, lack of pathognomonic signs, and inconclusive radiological features make the disease unsuspected in most cases, therefore delaying diagnosis and treatment. It usually presents at an advanced stage, and the prognosis is often poor. A high index of suspicion is warranted in patients with chronic kidney stone disease.PMID:37343206 | DOI:10.46883/2023.25920997
Source: Oncology (Williston Park, N.Y.) - June 21, 2023 Category: Cancer & Oncology Authors: Syed Arslan Shehzad Shah Naveed Ahmed Mahar Harris Hassan Qureshi Muddasir Hussain Gauhar Sultan Rehan Mohsin Altaf Hashmi Source Type: research

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13